The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rickey James Paul since 2019.
This trader's CIK number is 1606243.
At the time of last reporting, Rickey James Paul was the Chief Financial Officer of Braveheart Bio, Inc.. (stock ticker symbol BRVE).
Also see all insider trading activities at Braveheart Bio, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | BRVE | 27,777 | $499,986 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ALPN | 0 | $0 | 118,000 | $2,791,017 | 171,522 | $1,468,445 |
| 2023 | ALPN | 0 | $0 | 163,514 | $2,850,188 | 156,500 | $637,951 |
| 2019 | ALPN | 10,000 | $49,500 | 0 | $0 | 0 | $0 |
1. Braveheart Bio, Inc. (BRVE)
2. Alpine Immune Sciences, Inc. (ALPN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-07 | BRVE | Buy | 27,777 | 18.00 | 499,986 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-07 | ALPN | Option Ex | 26,761 | 7.80 | 208,816 |
| 2024-05-07 | ALPN | Option Ex | 26,761 | 7.80 | 208,816 |
| 2024-01-26 | ALPN | Sale | 117,764 | 23.66 | 2,785,825 |
| 2024-01-25 | ALPN | Sale | 236 | 22.00 | 5,192 |
| 2024-01-26 | ALPN | Option Ex | 117,764 | 8.91 | 1,049,277 |
| 2024-01-25 | ALPN | Option Ex | 236 | 6.51 | 1,536 |
| 2023-12-19 | ALPN | Option Ex | 15,213 | 5.02 | 76,369 |
| 2023-12-19 | ALPN | Sale | 15,213 | 19.21 | 292,226 |
| 2023-12-14 | ALPN | Sale | 11,600 | 19.00 | 220,411 |
| 2023-12-15 | ALPN | Sale | 45,387 | 19.09 | 866,392 |
| 2023-12-18 | ALPN | Option Ex | 1,800 | 5.02 | 9,036 |
| 2023-12-18 | ALPN | Sale | 1,800 | 19.00 | 34,203 |
| 2023-12-14 | ALPN | Option Ex | 11,600 | 5.02 | 58,231 |
| 2023-12-15 | ALPN | Option Ex | 45,387 | 5.02 | 227,842 |
| 2023-12-06 | ALPN | Sale | 6,446 | 16.08 | 103,651 |
| 2023-12-05 | ALPN | Sale | 418 | 16.01 | 6,693 |
| 2023-12-06 | ALPN | Option Ex | 6,446 | 3.23 | 20,820 |
| 2023-12-04 | ALPN | Sale | 63,947 | 16.06 | 1,026,860 |
| 2023-12-05 | ALPN | Option Ex | 418 | 3.23 | 1,350 |
| 2023-12-04 | ALPN | Option Ex | 63,947 | 3.23 | 206,548 |
| 2023-11-30 | ALPN | Sale | 700 | 16.00 | 11,200 |
| 2023-11-30 | ALPN | Option Ex | 700 | 3.23 | 2,261 |
| 2023-11-06 | ALPN | Sale | 18,003 | 16.03 | 288,552 |
| 2023-11-06 | ALPN | Option Ex | 10,989 | 3.23 | 35,494 |
| 2019-05-30 | ALPN | Buy | 10,000 | 4.95 | 49,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rickey James Paul (Chief Financial Officer of Braveheart Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.